Showing results (2651-2660 of 6,778) with videos related to
Sort By:
Pageof 678
Clinical Therapeutics|December 7, 2005
Advantages of new cardiovascular risk-assessment strategies in high-risk patients with hypertensionLuis M Ruilope, Julian SeguraClinical Therapeutics|January 12, 2015
Assessment of montelukast, doxofylline, and tiotropium with budesonide for the treatment of asthma: which is the best among the second-line treatment? A randomized trialMuhasaparur Ganesan Rajanandh, Arcot D Nageswari, Kaliappan IlangoClinical Therapeutics|November 1, 1989
Repository corticotropin injection as an adjunct to smoking cessation during the initial nicotine withdrawal period: results from a family practice clinicJ L McElhaneyClinical Therapeutics|July 28, 2015
Investigation of Potential Pharmacokinetic Interactions Between Teneligliptin and Metformin in Steady-state Conditions in Healthy AdultsYoshinobu Nakamaru, Yoshiharu Hayashi, Martin Davies, et al.Clinical Therapeutics|August 23, 2017
Gastrointestinal Adverse Events of Dipeptidyl Peptidase 4 Inhibitors in Type 2 Diabetes: A Systematic Review and Network Meta-analysisShanshan Wu, Sanbao Chai, Jun Yang, et al.Clinical Therapeutics|March 1, 1989
Effects of lisuride hydrogen maleate on ischemia-induced depletion of brain acetylcholine levels in gerbilsN Ogawa, K Haba, H Yoshikawa, et al.Clinical Therapeutics|September 4, 2017
Pharmacokinetics, Safety, and Tolerability of Tedizolid Phosphate After Single-dose Administration in Healthy Korean Male SubjectsYun Kim, Anhye Kim, SeungHwan Lee, et al.Clinical Therapeutics|October 17, 2017
Mapping the Landscape of Patient-centric Activities Within Clinical ResearchMary Jo Lamberti, Josephine AwatinClinical Therapeutics|October 18, 2017
Effects of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibition with Bococizumab on Lipoprotein Particles in Hypercholesterolemic SubjectsHong Wan, Barry Gumbiner, Tenshang Joh, et al.Pageof 678